Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 92-100

  Watters, Chase ^a   Everett, Jake A ^a   Haley, Cecily ^a   Clinton, Allie ^a   Rumbaugh, Kendra P ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEOXYRIBONUCLEASE; GENOMIC DNA; GENTAMICIN; HUMAN INSULIN; ISOPHANE INSULIN; MYELOPEROXIDASE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BIOFILM; CELL DEATH; CHRONIC DISEASE; COLONY FORMING UNIT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG TOLERABILITY; ENZYME ASSAY; FEMALE; GAUZE DRESSING; GLUCOSE BLOOD LEVEL; IMMUNE SYSTEM; INSULIN TREATMENT; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TREATMENT OUTCOME; WOUND DRESSING; WOUND INFECTION;

EID: 84890851760     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00651-13     Document Type: Article

References (59)

1. Cunningham AB. 2006. Biofilms: the hypertextbook. Montana State University, Bozeman, MT.
2. Stamm WE, Martin SM, Bennett JV. 1977. Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines. J. Infect. Dis. 136(Suppl):S151-S160. http://dx.doi.org/10.1093/infdis/136.Supplement.S151.
3. Fuxman Bass JI, Russo DM, Gabelloni ML, Geffner JR, Giordano M, Catalano M, Zorreguieta A, Trevani AS. 2010. Extracellular DNA: a major proinflammatory component of Pseudomonas aeruginosa biofilms. J. Immunol. 184:6386-6395. http://dx.doi.org/10.4049/jimmunol.0901640.
4. Wolcott RD, Rhoads DD, Dowd SE. 2008. Biofilms and chronic wound inflammation. J. Wound Care 17:333-341.
5. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6:269-275. http://dx.doi.org/10.1046/j.1462-5822.2004.00367.x.
6. Thomson CH. 2011. Biofilms: do they affect wound healing? Int. Wound J. 8:63-67. http://dx.doi.org/10.1111/j.1742-481X.2010.00749.x.
7. Jacobsen JN, Andersen AS, Sonnested MK, Laursen I, Jorgensen B, Krogfelt KA. 2011. Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa. Int. Wound J. 8:33-43. http://dx.doi.org/10.1111/j.1742-481X.2010.00741.x.
8. Wolcott RD, Ehrlich GD. 2008. Biofilms and chronic infections. JAMA 299:2682-2684. http://dx.doi.org/10.1001/jama.299.22.2682.
9. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW. 2011. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen. 19:1-9. http://dx.doi.org/10.1111/j.1524-475X.2010.00651.x.
10. Anwar H, Dasgupta MK, Costerton JW. 1990. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother. 34:2043-2046. http://dx.doi.org/10.1128/AAC.34.11.2043.
11. Gefen O, Balaban NQ. 2009. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol. Rev. 33:704-717. http://dx.doi.org/10.1111/j.1574-6976.2008.00156.x.
12. Watters C, DeLeon K, Trivedi U, Griswold JA, Lyte M, Hampel KJ, Wargo MJ, Rumbaugh KP. 2013. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med. Microbiol. Immunol. 202:131-141. http://dx.doi.org/10.1007/s00430-012-0277-7.
13. Gauglitz GG, Toliver-Kinsky TE, Williams FN, Song JQ, Cui WH, Herndon DN, Jeschke MG. 2010. Insulin increases resistance to burn wound infection-associated sepsis. Crit. Care Med. 38:202-208. http://dx.doi.org/10.1097/CCM.0b013e3181b43236.
14. Jeschke MG, Kulp GA, Kraft R, Finnerty CC, Mlcak R, Lee JO, Herndon DN. 2010. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am. J. Resp. Crit. Care Med. 182:351-359. http://dx.doi.org/10.1164/rccm.201002-0190OC.
15. Dandona P, Chaudhuri A, Mohanty P, Ghanim H. 2007. Antiinflammatory effects of insulin. Curr. Opin. Clin. Nutr. Metabolic Care 10:511-517. http://dx.doi.org/10.1097/MCO.0b013e3281e38774.
16. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. 2001. Insulin inhibits intranuclear nuclear factor kappa B and stimulates I kappa B in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metabolism 86:3257-3265. http://dx.doi.org/10.1210/jc.86.7.3257.
17. Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. 2008. Insulin suppresses LPS-induced iNOS and COX-2 expression and NFkappa B activation in alveolar macrophages. Cell. Physiol. Biochem. 22: 279-286. http://dx.doi.org/10.1159/000149806.
18. Kidd LB, Schabbauer GA, Luyendyk JP, Holscher TD, Tilley RE, Tencati M, Mackman N. 2008. Insulin activation of the phosphatidylinositol 3-kinase/protein kinase B (Akt) pathway reduces lipopolysaccharideinduced inflammation in mice. J. Pharmacol. Exp. Ther. 326:348-353. http://dx.doi.org/10.1124/jpet.108.138891.
19. Holloway BW, Krishnapillai V, Morgan AF. 1979. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102.
20. Brint JM, Ohman DE. 1995. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J. Bacteriol. 177:7155-7163.
21. Brown RL, Greenhalgh DG. 1997. Mouse models to study wound closure and topical treatment of infected wounds in healing-impaired and normal healing hosts. Wound Repair Regen. 5:198-204. http://dx.doi.org/10.1046/j.1524-475X.1997.50213.x.
22. Wolcott RD, Rumbaugh KP, James G, Schultz G, Phillips P, Yang Q, Watters C, Stewart PS, Dowd SE. 2010. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J. Wound Care 19:320-328.
23. Schneider T, Issekutz AC. 1996. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. J. Immunol. Methods 198:1-14.
24. van Gennip M, Christensen LD, Alhede M, Qvortrup K, Jensen PO, Hoiby N, Givskov M, Bjarnsholt T. 2012. Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo. Infect. Immun. 80:2601-2607. http://dx.doi.org/10.1128/IAI.06215-11.
25. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, Molin S. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146(Part 10):2395-2407.
26. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. 2002. Extracellular DNA required for bacterial biofilm formation. Science 295:1487. http://dx.doi.org/10.1126/science.295.5559.1487.
27. Spoering AL, Gilmore MS. 2006. Quorum sensing and DNA release in bacterial biofilms. Curr. Opin. Microbiol. 9:133-137. http://dx.doi.org/10.1016/j.mib.2006.02.004.
28. Tetz GV, Artemenko NK, Tetz VV. 2009. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob. Agents Chemother. 53:1204-1209. http://dx.doi.org/10.1128/AAC.00471-08.
29. Mulcahy H, Charron-Mazenod L, Lewenza S. 2008. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 4:e1000213. http://dx.doi.org/10.1371/journal.ppat.1000213.
30. Chiang WC, Nilsson M, Jensen PO, Hoiby N, Nielsen TE, Givskov M, Tolker-Nielsen T. 2013. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 57:2352-2361. http://dx.doi.org/10.1128/AAC.00001-13.
31. Aspe M, Jensen L, Melegrito J, Sun M. 2012. The role of alginate and extracellular DNA in biofilm-meditated Pseudomonas aeruginosa gentamicin. J. Exp. Microbiol. Immunol. 16:42-48.
32. Diegelmann RF, Evans MC. 2004. Wound healing: an overview of acute,fibrotic and delayed healing. Front. Biosci. 9:283-289. http://dx.doi.org/10.2741/1184.
33. Nabi AH, Islam LN, Rahman MM, Biswas KB. 2005. Polymorphonuclear neutrophil dysfunctions in streptozotocin-induced type 1 diabetic rats. J. Biochem. Mol. Biol. 38:661-667. http://dx.doi.org/10.5483/BMBRep.2005.38.6.661.
34. Saiki O, Negoro S, Tsuyuguchi I, Yamamura Y. 1980. Depressed immunological defence mechanisms in mice with experimentally induced diabetes. Infect. Immun. 28:127-131.
35. Glass EJ, Stewart J, Matthews DM, Collier A, Clarke BF, Weir DM. 1987. Impairment of monocyte "lectin-like" receptor activity in type 1 (insulin-dependent) diabetic patients. Diabetologia 30:228-231. http://dx.doi.org/10.1007/BF00270420.
36. Wilson RM, Reeves WG. 1986. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin. Exp. Immunol. 63:478-484.
37. Harrison JE, Schultz J. 1976. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1371-1374.
38. Loo DT. 2002. TUNEL assay. An overview of techniques. Methods Mol. Biol. 203:21-30. http://dx.doi.org/10.1385/1-59259-179-5:21.
39. de Torres C, Munell F, Ferrer I, Reventos J, Macaya A. 1997. Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain. Neurosci. Lett. 230:1-4. http://dx.doi.org/10.1016/S0304-3940(97)00445-X.
40. Jeruc J, Vizjak A, Rozman B, Ferluga D. 2006. Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis. Am. J. Kidney Dis. 48:410-418. http://dx.doi.org/10.1053/j.ajkd.2006.05.019.
41. Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, Bhasker V, Gordillo GM, Sen CK, Roy S. 2010. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 5:e9539. http://dx.doi.org/10.1371/journal.pone.0009539.
42. Austyn JM, Gordon S. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805-815. http://dx.doi.org/10.1002/eji.1830111013.
43. Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. 2004. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann. Surg. 240:340-349. http://dx.doi.org/10.1097/01.sla.0000133353.57674.cd.
44. Jeschke MG, Klein D, Bolder U, Einspanier R. 2004. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145:4084-4093. http://dx.doi.org/10.1210/en.2004-0592.
45. Jeschke MG, Klein D, Herndon DN. 2004. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 239:553-560. http://dx.doi.org/10.1097/01.sla.0000118569.10289.ad.
46. Przkora R, Herndon DN, Finnerty CC, Jeschke MG. 2007. Insulin attenuates the cytokine response in a burn wound infection model. Shock 27:205-208. http://dx.doi.org/10.1097/01.shk.0000238069.84826.1b.
47. Ramos AN, Cabral ME, Noseda D, Bosch A, Yantorno OM, Valdez JC. 2012. Antipathogenic properties of Lactobacillus plantarum on Pseudomonas aeruginosa: the potential use of its supernatants in the treatment of infected chronic wounds. Wound Repair Regen. 20:552-562. http://dx.doi.org/10.1111/j.1524-475X.2012.00798.x.
48. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M. 2008. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16:2-10. http://dx.doi.org/10.1111/j.1524-475X.2007.00283.x.
49. Jensen PO, Bjarnsholt T, Phipps R, Rasmussen TB, Calum H, Christoffersen L, Moser C, Williams P, Pressler T, Givskov M, Hoiby N. 2007. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153:1329-1338. http://dx.doi.org/10.1099/mic.0.2006/003863-0.
50. Schaber JA, Carty NL, McDonald NA, Graham ED, Cheluvappa R, Griswold JA, Hamood AN. 2004. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 53:841-853. http://dx.doi.org/10.1099/jmm.0.45617-0.
51. Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR. 2008. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 76:4414-4421. http://dx.doi.org/10.1128/IAI.00012-08.
52. Wu KK, Huan Y. 2008. Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. Chapter 5:Unit 5.47. http://dx.doi.org/10.1002/0471141755.ph0547s40.
53. Turina M, Fry DE, Polk HC, Jr. 2005. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit. Care Med. 33: 1624-1633. http://dx.doi.org/10.1097/01.CCM.0000170106.61978.D8.
54. Wheat LJ. 1980. Infection and diabetes mellitus. Diabetes Care 3:187-197. http://dx.doi.org/10.2337/diacare.3.1.187.
55. Naghibi M, Smith RP, Baltch AL, Gates SA, Wu DH, Hammer MC, Michelsen PB. 1987. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res. Clin. Pract. 4:27-35. http://dx.doi.org/10.1016/S0168-8227(87)80030-X.
56. Kaplan MJ, Radic M. 2012. Neutrophil extracellular traps: double-edged swords of innate immunity. J. Immunol. 189:2689-2695. http://dx.doi.org/10.4049/jimmunol.1201719.
57. Young RL, Malcolm KC, Kret JE, Caceres SM, Poch KR, Nichols DP, Taylor-Cousar JL, Saavedra MT, Randell SH, Vasil ML, Burns JL, Moskowitz SM, Nick JA. 2011. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One 6:e23637. http://dx.doi.org/10.1371/journal.pone.0023637.
58. Walker TS, Tomlin KL, Worthen GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML, Nick JA. 2005. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 73:3693-3701. http://dx.doi.org/10.1128/IAI.73.6.3693-3701.2005.
59. Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA. 2009. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J. Med. Microbiol. 58:492-502. http://dx.doi.org/10.1099/jmm.0.005728-0.